IBM Shifts Focus from Quantum Science to Industrial Capabilities
IBM's quantum computing efforts have garnered significant attention lately, but the company is shifting its narrative to focus on its industrial capabilities. Speaking before the chip industry, IBM emphasized that the bottleneck in quantum computing lies not in the science, but rather in manufacturing. This positioning is backed by recent research wins, including a collaboration with Oak Ridge National Laboratory and the Cleveland Clinic, where IBM computed nine molecular configurations of FLiBe, a molten salt relevant to tritium production in fusion reactors.
The company's quantum-centric supercomputing approach targets tritium extraction for future fusion plants. A separate effort by researchers using IBM's 156-qubit Heron processor achieved an error-mitigated simulation of a Floquet Ising magnet, outperforming classical methods without full error correction. This breakthrough could open the door to earlier commercial applications.
Washington is taking notice, with Congressman Nick Langworthy introducing the 'American Quantum Competitiveness Act', which aims to make the Commerce Department the lead agency for commercial quantum technology and shield supply chains from Chinese influence. The Quantum Industry Coalition, including Google and Microsoft alongside IBM, supports this measure.